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ovalbumin-pulsed antigen-presenting cells (4) or by crosslinking of either CD3 or a( TCR (5) . The ovalbuminbinding murine GIF suppressed anti-hapten antibody responses of syngeneic mice to dinitrophenyl derivatives of ovalbumin in a carrier-specific manner (4) , and shared several antigenic determinants with antigen-specific TsFs (5) . Furthermore, evidence was obtained that a nitrophenyl-specific TsF described by Okuda et al. (6) had GIF bioactivity and bound to an anti-GIF monoclonal antibody (mAb) (7) . These findings indicated that antigen-binding GIF may represent an antigen-specific TsF and suggested that the human GIF having affinity for homologous antigen may represent the human counterpart of murine TsF (3) .
Only limited information has been available on the biochemical properties and molecular basis of murine TsFs. However, several studies have strongly suggested a close relationship between murine TsFs and TCR a chain (8) (9) (10) . Furthermore, we recently succeeded in molecular cloning of cDNAs encoding murine and human GIF and showed that polyclonal antibodies -against recombinant mouse GIF reacted with hybridoma-derived mouse and human GIF (11) . In view of such progress, the present experiments were undertaken to establish mAbs specific for human antigen-binding GIF and to obtain biochemical evidence for the presence of antigen-specific human T-cell factors having affinity for nominal antigen. The results show that the 13-kDa GIF is a subunit of the antigen-binding T-cell factor. Existence of T-cell factors having affinity for nominal antigens is a controversial issue in cellular immunology. The majority of antigen-specific suppressor T-cell factors (TsFs), having affinity-for a protein antigen or synthetic hapten, were obtained from murine T cells and T-cell hybridomas (1) . Although the presence of similar factors from human T cells was predicted (2) , no biochemical studies of such factors has been carried out. In our previous studies on the generation of antigen-specific suppressor T (Ts) cells, we constructed human T-cell hybridomas from peripheral blood lymphocytes of a patient sensitive to honeybee venom and obtained T-cell hybridomas specific for bee venom phospholipase A2 (PLA2) (3) . These hybridomas expressed CD3 and af8 T-cell receptors (TCRs) and secreted glycosylation inhibiting factor (GIF), a 13-kDa lymphokine that switches normal T cells from the formation of glycosylated IgE-binding factor (IgE-BF) to the formation of unglycosylated IgE-BF. Upon crosslinking of CD3 or TCR, however, the majority of the GIFproducing hybridomas formed GIF having affinity for PLA2 (3) . These findings were in agreement with previous observations on ovalbumin-specific murine Ts hybridomas, which constitutively secrete GIF having no affinity for ovalbumin but produce ovalbumin-specific GIF upon stimulation with MATERIAL AND METHODS Antien and Antibodies. Lyophilized bee venom PLA2 was purchased from Sigma. Crystalline ovalbumin was purchased from Nutritional Biochemicals. Synthetic peptides corresponding to aa 7-22, 13-28, and 25-40 in PLA2 molecules were supplied by Howard Grey, Cytel (San Diego). The peptide corresponding to aa 19-35 in PLA2 was synthesized by Kirin Pharmaceutical Laboratory (Maebashi, Japan). All of the synthetic peptides were purified by HPLC, and their amino acid sequences were confirmed. Anti-human GIF mAb 388F1 has been described (3). Anti-human CD3 antibody was obtained from the mouse hybridoma SPV-T3b (12) , which was kindly supplied by J. E. deVries, DNAX. The mAbs were purified from ascitic fluid of hybridoma-injected BALB/c mice by protein A-Sepharose. Specifically purified goat antibodies against mouse IgG (13) and the IgG fraction of rabbit polyclonal antiserum against recombinant mouse GIF (11) were previously described. mAb 388F1 was coupled to Affi-Gel 10 (Bio-Rad) according to the manufacturer's protocol. Two to 3 mg of IgG was coupled to 1 ml Affi-Gel. Bee venom PLA2, synthetic peptide Abbreviations: GIF, glycosylation inhibiting factor; IgE-BF, IgEbinding factor; PLA2, bee venom phospholipase A2; Ts cell, suppressor T cell; TsF, Ts factor; BSA, bovine serum albumin; mAb, monoclonal antibody.
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Cell Lines. Human T-cell hybridoma AC5 cells (3) were adapted to and cultured in protein-free ABC medium (Cell Biotechnology, Rockville, MD). Mouse T-cell hybridoma 12H5 cells (14) were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 10% NCTC 135 medium (GIBCO), 10 mM Hepes buffer, bovine insulin (0.2 unit/ml; Sigma), sodium pyruvate (50 ug/ml), oxaloacetic acid (150 pug/ml), and antibiotics. B-cell hybridomas were constructed from spleen cells of BALB/c mice (The Jackson Laboratory) that had been immunized with affinity-purified antigen-binding GIF (see below). One week after the last booster immunization, their spleen cells were fused with hypoxanthine phosphoribosyltransferase-deficient Sp2/0 Agl4 cells (15) . Subcloning of the hybridomas was carried out by limiting dilution. The hybridomas were maintained in the supplemented DMEM described above.
Detection of GIF. GIF was detected by the capacity of this cytokine to switch 12H5 cells from the formation of glycosylated IgE-BF to the formation of unglycosylated IgE-BF (16) . In brief, aliquots of the 12H5 cells were cultured for 24 hr with mouse IgE in the presence or absence of a sample to be tested, and culture filtrates were fractionated on lentil lectin-Sepharose. IgE-BF in the effluent fraction and eluate with methyl a-D-mannoside was determined by rosette inhibition of FcE receptor-positive cells with IgE-coated ox erythrocytes. When the 12H5 cells were cultured with IgE alone, essentially all IgE-BF formed by the cells bound to lentil lectin-Sepharose and was recovered by elution with methyl a-D-mannoside. When a sufficient amount of GIF was added to the culture of 12H5 cells together with IgE, the majority of IgE-BF formed by the cells failed to be retained in the lentil lectin-Sepharose and was recovered in the effluent fraction (16) . A test sample was taken as GIFpositive if the ratio of the percent rosette inhibition between the effluent and eluate fractions was 2.0 or higher.
Fractionation and Purification of GIF. Nonspecific GIF in culture supernatants of unstimulated AC5 cells was partially purified by chromatography on a DEAE-Sepharose column equilibrated with 10 mM Tris HCl, pH 8.0/50 mM NaCl (3). The flowthrough fraction and buffer wash of the column were concentrated. Nonspecific GIF in the original culture supernatant was affinity-purified by using 388F1-coupled Affi-Gel as described (3) .
To produce antigen-binding GIF, AC5 cells were stimulated by crosslinking of CD3 (3). The cells (5 x 106 per ml)
were treated with anti-CD3 mAb (5 ,g/ml) for 30 min at 4°C, and the antibody-treated cells were incubated for 30 min at 4°C with anti-mouse IgG (10 pg/ml). After washing, the cells were suspended in ABC medium at 2 x 106 cells per ml and cultured for 24 hr. Antigen-binding GIF was purified by adsorption of culture supernatant with PLA2-coupled Sepharose in the presence of 10 mM EDTA and recovered by elution with 0.1 M glycine/HCl buffer at pH 3.0 (3). Affinitypurified GIF was fractionated by gel filtration on a Superose 12 column (1.6 cm x 50 cm; Pharmacia) connected to an HPLC instrument (Beckman System Gold, Fullerton, CA), as described (3). The column was calibrated with bovine serum albumin (BSA) (Mr 67,000), ovalbumin (Mr 43,000), soybean trypsin inhibitor (Mr 20,100) and cytochrome c (Mr 12,500). In some experiments, an affinity-purified GIF preparation was reduced and alkylated. The GIF preparation in 0.05 M Tris HCl, pH 8.5/0.15 M NaCl was incubated for 1 hr at room temperature with 10 mM dithiothreitol and then alkylated with a 30% molar excess of iodoacetamide.
ELISAs. Each well of a Nunc F plate (Max Sorp; Nunc)
was coated with 50 gl of serial dilutions of a GIF preparation overnight at 40C in duplicate or triplicate. Plates were washed five times with phosphate-buffered saline containing 0.05% Tween 20 (Sigma) (Tween/PBS) between each of the following steps except the step prior to substrate. The plates were blocked with 2% BSA in Tween/PBS for 1 hr at 370C. Binding of mAb 388F1 to GIF-coated wells was determined with an amplification system (17) . Fifty microliters ofPBS containing biotinylated mAb 388F1 at 150 ng/ml was added to each well.
After a 2-hr incubation at 370C followed by washing, 50 ,ul of an appropriate dilution (1:6000) of streptavidin-coupled alkaline phosphatase (Zymed) was added to each well and the plate was incubated for 2 hr at 370C. The plate was washed with 0.05% Tween 20 in 0.05 M Tris HCl, pH 7.5/0.15 M NaCl, and an ELISA signal was developed by 30 min of incubation with 50 ,ul of alkaline phosphatase substrate followed by amplifier solution (GIBCO/BRL). A490 was determined in a Dynatek MRC 5000 ELISA reader. An ELISA was also set up with mAb against antigenbinding GIF. After Max-Sorp plates were coated with a GIF preparation and blocked with BSA, 50 ul of the mAb (200 ng/ml) in PBS was added to each well and the plate was incubated for 2 hr at 37°C. Depending on the isotype of the mAb, a 1:3000 dilution of horseradish perotidase-coupled goat anti-mouse IgM (Bio-Rad) or anti-mouse tgo (Zymed) or a 1:2000 dilution of horseradish peroxidase-coupled antimouse IgG/A/M (Zymed) was added to each well. The ELISA signal was developed by peroxidase substrate (Zymed) and determined by A405.
SDS/PAGE and Immunoblotting. Affinity-purified GIF was dialyzed against 0.01% SDS and lyophilized. Samples were then analyzed by SDS/PAGE in a 15% polyacrylamide slab gel with the Laemmli system (18). Purified recombinant GIF from Escherichia coli (11) was electrophoresed in parallel as a standard. Immunoblotting was carried out with enhanced chemiluminescence (ECL) Western blot detection reagents (Amersham). Detailed procedures were described in a previous article (11) .
RESULTS
Preparation of mAbs Specific for Antigen-Binding GIF. The PLA2-binding GIF from AC5 cells was affinity purified by using PLA2-coupled Sepharose. The preparation could switch 12H5 cells from the formation of glycosylated IgE-BF to the formation of unglycosylated IgE-BF at a dilution of 1:30 to 1:60. BALB/c mice were immunized by an intraperitoneal injection of 0. mAb 11OBH3 from the culture supernatant of the hybridoma was enriched by precipitation with ammonium sulfate (33% saturation), and 5 mg of IgM was coupled to 1.5 ml of CL-Sepharose 4B. The PLA2-binding GIF and nonspecific GIF from the AC5 cells were then fractionated on the antibody-coupled Sepharose. PLA2-binding GIF bound to the immunosorbent and was recovered by elution at acid pH, whereas nonspecific GIF failed to be retained.
Attempts were made to detect antigen-binding GIF and nonspecific GIF by ELISA. The antigen-binding factors in the culture supernatants of anti-CD3-stimulated cells were partially purified by using PLA2-coupled Sepharose, and the factors in acid eluates were further purified by 11OBH3-coupled Sepharose. mAb 388F1 gave ELISA signals with both nonspecific GIF and antigen-binding GIF preparations, whereas mAb 11OBH3 reacted with antigen-binding factor but not with the nonspecific GIF (Fig. 1) .
The preparation ofthe antigen-binding factor was analyzed by SDS/PAGE (Fig. 2A) . Under nonreducing conditions, the preparation gave three major bands of 85, 66, and 58 kDa and a minor band of 13 kDa. Under reducing conditions, the 85-kDa band disappeared and several new bands were detected. Since one ofthe major bands detected under reducing conditions was at 13 kDa, corresponding in mobility to nonspecific GIF (3), a partially purified PLA2-binding GIF was analyzed by SDS/PAGE under reducing conditions followed by immunoblotting with polyclonal antibodies against recombinant GIF. The antibodies recognized the 13-kDa band (Fig. 2B, lane 1) . The relationship between the 13-kDa band and nonspecific GIF was confirmed by immu- noblotting of nonspecific GIF, which was purified from culture supernatant of unstimulated AC5 cells by affinity chromatography on 388Fl-coupled Affi-Gel (lane 2).
We suspected that the 13-kDa GIF and the antigen-binding polypeptide chain were associated with each other to form antigen-binding GIF. If this is the case, molecular size of antigen-binding GIF should be larger than that of nonspecific GIF. To test this possibility, PLA2-binding GIF from AC5 cells was partially purified by using 11OBH3-Sepharose, and the preparation was fractionated by Superose 12 gel filtration. Each fraction was assessed for the presence of antigenbinding GIF by ELISA. The majority of GIF, as detected by mAb 388F1, was eluted from the Superose column between 55.5 and 60.5 min (Fig. 3A) . The size of the molecule, estimated from its elution time, was 72-80 kDa. As expected, the fractions contained GIF activity as determined by bioassay. The same fractions gave ELISA signal with mAb 11OBH3. The results strongly suggest that the two distinct antigenic determinants recognized by mAbs 388F1 and 11OBH3 are associated with the same molecules.
If the antigen-specific GIF actually consists of antigenbinding chain and nonspecific GIF, one might expect that the antigen-binding GIF may be dissociated into separate polypeptides by reduction and alkylation. Thus, the affinitypurified antigen-binding GIF was reduced and alkylated, and the sample was applied to the same Superose 12 column. Distribution of 388F1 antigen and 11OBH3 antigen, determined by ELISA, indicated that approximately half of the GIF in the reduced and alkylated material was recovered in a fraction whose elution time corresponded to 15 Da (Fig.  3B) . The experiment also showed two peaks of molecules recognized by 11OBH3; the first peak corresponded to the original antigen-binding GIF, while the elution time of the second peak corresponded to 62-64 kDa. Since the latter fraction did not contain the GIF determinant recognized by 388F1, the 11OBH3-positive protein in the fraction probably represented a cleavage product of antigen-binding GIF.
Epitope Specicity of Anft=ge-BhdIng GIF. Experiments were carried out to confirm that the PLArbinding GIF was specific for bee venom PLA2. As expected, PLArbinding GIF from ACS cells failed to be retained by ovalbumin- (Fig. 3) . Association of the 13-kDa GIF with the antigen-binding DISCUSSION factor was confirmed by immunoblot analysis with polyclonal antibodies against recombinant GIF (Fig. 2B) [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] probably contains the epitope specific for the factor. The x-ray crystal structure of PLA2 indicates that this sequence represents an external structure of PLA2 (19, 26) , and this explains why the factor could bind to the nominal antigen.
In the murine systems, evidence indicates that both the antigen-binding GIF and the effector-type TsF consist of multiple polypeptide chains (27) (28) (29) . The ovalbumin-binding GIF from murine Ts hybridomas had a molecular mass of about 80 kDa as estimated by gel filtration (4) . The present finding that the human PLA2-binding GIF consists ofmultiple polypeptide chains and has a molecular mass of 72-80 kDa suggests that the T-cell factor is a counterpart of mouse TsF. Further studies are required to determine whether the antigen-binding human GIF can actually suppress antibody formation by human lymphocytes in an antigen-specific manner.
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